IL1B and neoplasm: IDO‐1, KYNU, PAPP‐A, and IL‐1B were not upregulated in CEF‐CM‐treated CAFs, suggesting that CEFs do not amplify pre‐existing CAF function, but that newly differentiated CEFs can promote tumor progression.